Literature DB >> 20308559

P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis.

Munekazu Yamakuchi1, Craig D Lotterman, Clare Bao, Ralph H Hruban, Baktiar Karim, Joshua T Mendell, David Huso, Charles J Lowenstein.   

Abstract

The pathway involving the tumor suppressor gene TP53 can regulate tumor angiogenesis by unclear mechanisms. Here we show that p53 regulates hypoxic signaling through the transcriptional regulation of microRNA-107 (miR-107). We found that miR-107 is a microRNA expressed by human colon cancer specimens and regulated by p53. miR-107 decreases hypoxia signaling by suppressing expression of hypoxia inducible factor-1beta (HIF-1beta). Knockdown of endogenous miR-107 enhances HIF-1beta expression and hypoxic signaling in human colon cancer cells. Conversely, overexpression of miR-107 inhibits HIF-1beta expression and hypoxic signaling. Furthermore, overexpression of miR-107 in tumor cells suppresses tumor angiogenesis, tumor growth, and tumor VEGF expression in mice. Finally, in human colon cancer specimens, expression of miR-107 is inversely associated with expression of HIF-1beta. Taken together these data suggest that miR-107 can mediate p53 regulation of hypoxic signaling and tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308559      PMCID: PMC2851979          DOI: 10.1073/pnas.0911082107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Signal transduction. How do cells sense oxygen?

Authors:  H Zhu; H F Bunn
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

Review 2.  Regulation of angiogenesis by hypoxia: role of the HIF system.

Authors:  Christopher W Pugh; Peter J Ratcliffe
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 3.  HIF hydroxylation and the mammalian oxygen-sensing pathway.

Authors:  Michal Safran; William G Kaelin
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

4.  Suppression of tumor growth through disruption of hypoxia-inducible transcription.

Authors:  A L Kung; S Wang; J M Klco; W G Kaelin; D M Livingston
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

5.  Effect of p53 status on tumor response to antiangiogenic therapy.

Authors:  Joanne L Yu; Janusz W Rak; Brenda L Coomber; Daniel J Hicklin; Robert S Kerbel
Journal:  Science       Date:  2002-02-22       Impact factor: 47.728

Review 6.  Decision making by p53: life, death and cancer.

Authors:  M Oren
Journal:  Cell Death Differ       Date:  2003-04       Impact factor: 15.828

Review 7.  Cancer genes and the pathways they control.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

Review 8.  VEGF and the quest for tumour angiogenesis factors.

Authors:  Napoleone Ferrara
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

Review 10.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

View more
  186 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

2.  p53-Dependent induction of PVT1 and miR-1204.

Authors:  Anthony M Barsotti; Rachel Beckerman; Oleg Laptenko; Konrad Huppi; Natasha J Caplen; Carol Prives
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

Review 3.  Role of microRNAs in endothelial inflammation and senescence.

Authors:  Bing Qin; Huan Yang; Bo Xiao
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

Review 4.  The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.

Authors:  John R Finnerty; Wang-Xia Wang; Sébastien S Hébert; Bernard R Wilfred; Guogen Mao; Peter T Nelson
Journal:  J Mol Biol       Date:  2010-08-01       Impact factor: 5.469

Review 5.  Invited review: decoding the microRNA response to hypoxia.

Authors:  Roger Pocock
Journal:  Pflugers Arch       Date:  2011-01-05       Impact factor: 3.657

6.  Discordant expression of miR-103/7 and pantothenate kinase host genes in mouse.

Authors:  Brenda J Polster; Shawn K Westaway; Thuy M Nguyen; Moon Y Yoon; Susan J Hayflick
Journal:  Mol Genet Metab       Date:  2010-08-04       Impact factor: 4.797

7.  MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.

Authors:  Chao Zou; Qing Xu; Feng Mao; Dan Li; Chuanxiu Bian; Ling-Zhi Liu; Yue Jiang; Xiaona Chen; Yanting Qi; Xiaolong Zhang; Xuejing Wang; Qiang Sun; Hsiang-Fu Kung; Marie C Lin; Andreas Dress; Fiona Wardle; Bing-Hua Jiang; Lihui Lai
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

Review 8.  Tumor angiogenesis: molecular pathways and therapeutic targets.

Authors:  Sara M Weis; David A Cheresh
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

9.  Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway.

Authors:  Xiaodong Ma; Saibyasachi N Choudhury; Xiang Hua; Zhongping Dai; Yong Li
Journal:  Carcinogenesis       Date:  2013-02-05       Impact factor: 4.944

10.  Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review).

Authors:  Jie Zheng
Journal:  Oncol Lett       Date:  2012-09-20       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.